Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Number of holders
-
71
-
Total 13F shares, excl. options
-
360,483,554
-
Shares change
-
+11,295,773
-
Total reported value, excl. options
-
$1,467,028,314
-
Value change
-
+$45,607,814
-
Put/Call ratio
-
1.15%
-
Number of buys
-
51
-
Number of sells
-
-14
-
Price
-
$4.07
Significant Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q2 2022
86 filings reported holding ROIV - Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share as of Q2 2022.
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 360,483,554 shares
of 695,088,397 outstanding shares and own 51.86% of the company stock.
Largest 10 shareholders include QVT Financial LP (129,393,817 shares), SB INVESTMENT ADVISERS (UK) LTD (99,375,586 shares), VIKING GLOBAL INVESTORS LP (88,238,700 shares), BlackRock Inc. (5,428,058 shares), SC CHINA HOLDING Ltd (5,205,418 shares), Anchorage Capital Group, L.L.C. (4,832,642 shares), Two Seas Capital LP (3,419,836 shares), Palantir Technologies Inc. (3,000,000 shares), FMR LLC (2,500,000 shares), and AMERICAN INTERNATIONAL GROUP, INC. (1,814,697 shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.